ERBB2 and breast cancer: Moreover, a biomimetic nanoplatform consisting of a combination of CAR-NK cell-derived exosomes (ExoCAR) and a nanobomb, produced a strong antitumor response in vivo against HER2-expressing breast cancer brain metastases, increasing mice survival (97).